SI21637A - Farmacevtska oblika z nadzorovanim sproščanjem - Google Patents

Farmacevtska oblika z nadzorovanim sproščanjem Download PDF

Info

Publication number
SI21637A
SI21637A SI200300317A SI200300317A SI21637A SI 21637 A SI21637 A SI 21637A SI 200300317 A SI200300317 A SI 200300317A SI 200300317 A SI200300317 A SI 200300317A SI 21637 A SI21637 A SI 21637A
Authority
SI
Slovenia
Prior art keywords
coating
pharmaceutical
polymer
pharmaceutical form
form according
Prior art date
Application number
SI200300317A
Other languages
English (en)
Slovenian (sl)
Inventor
Polonca Kuhar
Judita �irca
Original Assignee
LEK farmacevtska dru�ba d.d.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LEK farmacevtska dru�ba d.d. filed Critical LEK farmacevtska dru�ba d.d.
Priority to SI200300317A priority Critical patent/SI21637A/sl
Priority to ARP040104829A priority patent/AR048138A1/es
Priority to RU2006126786/15A priority patent/RU2447884C2/ru
Priority to EP04809252A priority patent/EP1699439A2/fr
Priority to BRPI0418122-0A priority patent/BRPI0418122A/pt
Priority to US10/583,440 priority patent/US20070141149A1/en
Priority to PCT/SI2004/000044 priority patent/WO2005060939A2/fr
Priority to AU2004305422A priority patent/AU2004305422B2/en
Priority to CA2547586A priority patent/CA2547586C/fr
Priority to JP2006546934A priority patent/JP2007516282A/ja
Priority to CNA2004800388929A priority patent/CN1897923A/zh
Publication of SI21637A publication Critical patent/SI21637A/sl
Priority to ZA200603656A priority patent/ZA200603656B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200300317A 2003-12-23 2003-12-23 Farmacevtska oblika z nadzorovanim sproščanjem SI21637A (sl)

Priority Applications (12)

Application Number Priority Date Filing Date Title
SI200300317A SI21637A (sl) 2003-12-23 2003-12-23 Farmacevtska oblika z nadzorovanim sproščanjem
ARP040104829A AR048138A1 (es) 2003-12-23 2004-12-21 Formulacion farmaceutica de liberacion controlada
US10/583,440 US20070141149A1 (en) 2003-12-23 2004-12-22 Controlled-release pharmaceutical formulation
EP04809252A EP1699439A2 (fr) 2003-12-23 2004-12-22 Formulation pharmaceutique a liberation controlee
BRPI0418122-0A BRPI0418122A (pt) 2003-12-23 2004-12-22 formulação farmacêutica de liberação controlada
RU2006126786/15A RU2447884C2 (ru) 2003-12-23 2004-12-22 Фармацевтический состав с контролируемым высвобождением действующего вещества
PCT/SI2004/000044 WO2005060939A2 (fr) 2003-12-23 2004-12-22 Formulation pharmaceutique a liberation controlee
AU2004305422A AU2004305422B2 (en) 2003-12-23 2004-12-22 Controlled-release pharmaceutical formulation
CA2547586A CA2547586C (fr) 2003-12-23 2004-12-22 Formulation pharmaceutique a liberation controlee
JP2006546934A JP2007516282A (ja) 2003-12-23 2004-12-22 放出制御医薬製剤
CNA2004800388929A CN1897923A (zh) 2003-12-23 2004-12-22 控释药物制剂
ZA200603656A ZA200603656B (en) 2003-12-23 2006-05-09 Controlled-release pharmaceutical formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SI200300317A SI21637A (sl) 2003-12-23 2003-12-23 Farmacevtska oblika z nadzorovanim sproščanjem

Publications (1)

Publication Number Publication Date
SI21637A true SI21637A (sl) 2005-06-30

Family

ID=34709497

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200300317A SI21637A (sl) 2003-12-23 2003-12-23 Farmacevtska oblika z nadzorovanim sproščanjem

Country Status (12)

Country Link
US (1) US20070141149A1 (fr)
EP (1) EP1699439A2 (fr)
JP (1) JP2007516282A (fr)
CN (1) CN1897923A (fr)
AR (1) AR048138A1 (fr)
AU (1) AU2004305422B2 (fr)
BR (1) BRPI0418122A (fr)
CA (1) CA2547586C (fr)
RU (1) RU2447884C2 (fr)
SI (1) SI21637A (fr)
WO (1) WO2005060939A2 (fr)
ZA (1) ZA200603656B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006232696A (ja) * 2005-02-23 2006-09-07 Taisho Pharm Ind Ltd 徐放性製剤
JP5524624B2 (ja) * 2007-11-16 2014-06-18 旭化成ケミカルズ株式会社 水系フィルムコーティング液、および、フィルムコーティング顆粒、ならびに、これを用いた錠剤
KR101689688B1 (ko) * 2008-11-18 2016-12-26 유씨비 파마, 에스.에이. ２­옥소­１­피롤리딘 유도체를 포함하는 지연 방출형 제형
CN118284408A (zh) 2021-10-25 2024-07-02 法玛利德尔公司 他达拉非经口混悬剂
CN115300506A (zh) * 2022-08-11 2022-11-08 南京红地生物科技有限公司 含有坦索罗辛和米拉贝隆的复方制剂及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772475A (en) * 1985-03-08 1988-09-20 Yamanouchi Pharmaceutical Co., Ltd. Controlled-release multiple units pharmaceutical formulation
PH27186A (en) * 1989-09-07 1993-04-16 Ciba Geigy Ag Double-coated granules of disodium pamidronate
US5041430A (en) * 1989-09-18 1991-08-20 Du Pont Mereck Pharmaceutical Company Oral anticoagulant/platelet inhibitor low dose formulation
ZA919510B (en) * 1990-12-05 1992-10-28 Smithkline Beecham Corp Pharmaceutical compositions
EP0520119A1 (fr) * 1991-06-17 1992-12-30 Spirig Ag Pharmazeutische Präparate Composition à base de diclofenac pour l'administration orale
GB9117361D0 (en) * 1991-08-12 1991-09-25 Euro Celtique Sa Oral dosage form
AU8604098A (en) * 1997-08-01 1999-02-22 Acushnet Company Golf ball and method of making same
EA002806B1 (ru) * 1997-09-11 2002-10-31 Нюкомед Данмарк А/С Многоединичные композиции с модифицированным высвобождением нестероидных противовоспалительных лекарственных веществ (nsaid)
US6602522B1 (en) * 1997-11-14 2003-08-05 Andrx Pharmaceuticals L.L.C. Pharmaceutical formulation for acid-labile compounds
WO2001062195A1 (fr) * 2000-02-24 2001-08-30 Advancis Pharmaceutical Corporation Compositions antibiotiques et antifongiques
US6610328B2 (en) * 2000-02-24 2003-08-26 Advancis Pharmaceutical Corp. Amoxicillin-clarithromycin antibiotic composition
KR100530546B1 (ko) * 2001-07-27 2005-11-23 아스텔라스세이야쿠 가부시키가이샤 구강내에서 신속하게 붕괴되는 정제용 서방성 미립자가함유된 조성물 및 그의 제조 방법
KR20040081446A (ko) * 2002-01-04 2004-09-21 아이박스 리서치, 인코포레이티드 글리피지드의 서방성을 위한 약물 전달 체계
US7018658B2 (en) * 2002-11-14 2006-03-28 Synthon Bv Pharmaceutical pellets comprising tamsulosin

Also Published As

Publication number Publication date
EP1699439A2 (fr) 2006-09-13
RU2447884C2 (ru) 2012-04-20
CA2547586C (fr) 2012-12-04
AR048138A1 (es) 2006-04-05
JP2007516282A (ja) 2007-06-21
BRPI0418122A (pt) 2007-04-17
ZA200603656B (en) 2007-09-26
AU2004305422A1 (en) 2005-07-07
RU2006126786A (ru) 2008-01-27
WO2005060939A3 (fr) 2005-12-29
CN1897923A (zh) 2007-01-17
WO2005060939A2 (fr) 2005-07-07
CA2547586A1 (fr) 2005-07-07
US20070141149A1 (en) 2007-06-21
AU2004305422B2 (en) 2010-12-23

Similar Documents

Publication Publication Date Title
US5529790A (en) Delayed, sustained-release diltiazem pharmaceutical preparation
KR100735509B1 (ko) 지연 작용을 갖는 경구 약제학적 투여 형태
AU760006B2 (en) Method for making granules with masked taste and instant release of the active particle
US8968777B2 (en) Tranexamic acid formulations with reduced adverse effects
CA2415840C (fr) Pastilles pharmaceutiques comprenant de la tamsulosine et processus de fabrication de ces pastilles
EP0194838A2 (fr) Formulation pharmaceutique à libération contrôlée
CZ2002671A3 (cs) Léková forma se zpoľděným účinkem obsahující tramadolsacharinát
JP2001526213A (ja) 経口医薬パルス放出剤形
BR112013003581B1 (pt) Composição farmacêutica ou nutracêutica gastro resistente, que compreende um ou mais sais do ácido algínico, e seu processo de produção
CN102046155A (zh) 包含多颗粒的具有双重释放特性的固体口服剂型
US20150140089A1 (en) Novel formulations of nitrofurans including nifurtimox with enhanced activity with lower toxicity
ZA200603656B (en) Controlled-release pharmaceutical formulation
WO2001087269A1 (fr) Une composition de pellicule pour faciliter la liberation regulee
WO2004024128A2 (fr) Composition pharmaceutique a liberation modifiee
WO2009065130A2 (fr) Formulations à libération modifiée de diltiazème
US20030157174A1 (en) Enteric granular preparations of hardly water soluble drugs characterized by containing water-repellent component
CZ118899A3 (cs) Kompozice s pozvolným uvolňováním léčiva, způsob přípravy této kompozice, způsob zlepšení profilu uvolňování léčiva a použití této kompozice
JP4840793B2 (ja) 撥水性成分を配合することを特徴とする難水溶性薬物の腸溶顆粒製剤
MXPA06007316A (en) Controlled-release pharmaceutical formulation
RU2292877C2 (ru) Лекарственная ретард-форма, содержащая сахаринат трамадола
OA20182A (en) A process for the preparation of a modified release multiple unit oral dosage form of doxylamine succinate and pyridoxine hydrochloride.
Rhee et al. Controlled-release pelletized dosage forms using the extrusion-spheronization process

Legal Events

Date Code Title Description
OO00 Grant of patent

Effective date: 20040316

KO00 Lapse of patent

Effective date: 20140205